Assessment of albumin-related inflammatory indices in preeclampsia and their relationship with composite adverse perinatal outcomes
Open Access
- 4 May 2026
- journal article
- research article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Abstract
Background: Preeclampsia is characterized by systemic inflammation, endothelial dysfunction, and multi-organ involvement, contributing to increased risk of adverse perinatal outcomes. Albumin-based inflammatory and nutritional indices have recently gained interest as easily accessible biomarkers in high-risk pregnancies. This study aimed to compare albumin-related indices between preeclamptic and normotensive pregnancies and to evaluate their predictive value for composite adverse perinatal outcomes (CAPO) in preeclampsia. Methods: This retrospective case–control study included 186 preeclamptic patients and 186 healthy controls matched for maternal age, BMI, gravidity, and gestational age. Laboratory parameters measured at delivery and calculated indices (NAR, FAR, sACR, HALP, and BAR) were compared. The preeclampsia cohort was further classified into CAPO (+) and CAPO (–) groups. Logistic regression models were used to identify independent predictors of CAPO, and receiver operating characteristic (ROC) analysis assessed predictive performance. Results: Albumin-based indices differed significantly between preeclamptic and healthy pregnancies, with higher NAR, FAR, and BAR values and lower sACR levels in the preeclampsia group (all p < 0.001). Among preeclamptic patients, CAPO developed in 44.1% ( n = 82). CAPO (+) patients demonstrated higher NAR, BAR, and HALP values and lower sACR levels compared to CAPO (–) patients. In multivariable logistic regression, only the blood urea nitrogen-to-albumin ratio (BAR) remained independently associated with CAPO (aOR = 1.157, p = 0.015). BAR demonstrated moderate discriminative performance for CAPO (AUC = 0.718; cut-off > 0.61; sensitivity 67.1%; specificity 69.2%; p < 0.001). Conclusion: All albumin-based indices showed significant alterations in preeclampsia; however, only BAR independently predicted adverse perinatal outcomes. BAR is a simple, inexpensive biomarker derived from routine laboratory parameters and may support risk stratification and neonatal outcome prediction in preeclamptic pregnancies. Prospective multicenter studies are warranted to validate its clinical applicability.Keywords
This publication has 36 references indexed in Scilit:
- Evaluation of albumin-based inflammatory markers as diagnostic tools in HELLP syndromeScientific Reports, 2025
- sFlt-1, Coagulation Function, and Platelets as Predictors of PreeclampsiaJournal of Obstetrics and Gynaecology Canada, 2025
- Causal Relationship Between Inflammation and Preeclampsia: Genetic Evidence from a Mendelian Randomization StudyTwin Research and Human Genetics, 2023
- The role of immune cells and mediators in preeclampsiaNature Reviews Nephrology, 2023
- The predictive value of fibrinogen‐to‐albumin ratio in the active, severe active, and poor prognosis of systemic lupus erythematosus: A single‐center retrospective studyJournal of Clinical Laboratory Analysis, 2022
- Blood urea nitrogen to albumin ratio is a predictor of in-hospital mortality in older emergency department patientsThe American Journal of Emergency Medicine, 2021
- Incidence and risk factors for Preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control studyScientific Reports, 2019
- Pre-eclampsia: pathogenesis, novel diagnostics and therapiesNature Reviews Nephrology, 2019
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Uteroplacental ischemia in early‐ and late‐onset pre‐eclampsia: a role for the fetus?Ultrasound in Obstetrics & Gynecology, 2012